Sight Sciences (SGHT)
Develops interventional devices for glaucoma surgery and dry eye treatment.
$8.59
After hours−0.01 (−0.06%)
At close$8.60(+1.24%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 40.75% | 22.45M shares | |
|---|---|---|---|
| 115 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 47.07% | 25.93M shares | |
| 20 holders · as of Aug 18, 2026 | |||
| Other | ≈ 12.18% | 6.71M shares | |
| remainder | |||
55.09M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
115 holders · 22.45M shares · 19 new positions · 64 increased · 31 reduced · 18 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Long Focus Capital Management, LLC | 3.84M | 6.98% | +250.0K | Aug 14, 2026 |
| BlackRock, Inc. | 3.08M | 5.60% | +251.2K | Aug 7, 2026 |
| Americana Partners, LLC | 1.68M | 3.05% | +52 | Aug 5, 2026 |
| Pathstone Holdings, LLC | 1.68M | 3.05% | −718.4K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.57M | 2.86% | +121.1K | Aug 13, 2026 |
| B Group, Inc. | 970.0K | 1.76% | 0 | Aug 14, 2026 |
| Geode Capital Management, LLC | 958.6K | 1.74% | +43.1K | Aug 12, 2026 |
| State Street Corp | 835.5K | 1.52% | +424 | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Staffan Encrantzincl. Allegro Investment Fund, L.P., Allegro Investment Inc. | 13.10% | 6.73M | 13D | Mar 13, 2025 |
| Long Focus Capital Management, LLC | 6.00% | 3.13M | 13G | May 15, 2025 |
| BlackRock, Inc. | 5.01% | 2.65M | 13G | Jan 21, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 1, 2026 | Paul Badawidirector, 10 percent owner, officer: President and CEO | Sale | 28,684 | $5.42 | 6,122,472 |
| Jul 2, 2026 | Alison Bauerleinofficer: Chief Operating Officer | Sale | 24,184 | $5.36 | 664,709 |
| Jul 1, 2026 | Brenton Taylorofficer: EVP, Operations & R&D | Sale | 2,829 | $5.42 | 264,978 |
| Jul 6, 2026 | David Badawidirector, officer: Chief Technology Officer | Sale | 7,418 | $5.51 | 1,982,872 |
| Jul 2, 2026 | James Rodbergofficer: Chief Financial Officer | Sale | 6,902 | $5.36 | 224,037 |
| Jul 6, 2026 | Jeremy B. Haydenofficer: Chief Legal Officer | Sale | 12,733 | $5.51 | 357,037 |
| Jun 10, 2026 | Staffan Encrantzdirector, 10 percent owner: | Purchase | 14,100 | $4.88 | 1,434,283 |
| May 18, 2026 | Alison Bauerleinofficer: Chief Operating Officer | Sale | 12,728 | $5.12 | 688,893 |
| Apr 6, 2026 | Jeremy B. Haydenofficer: Chief Legal Officer | Sale | 13,761 | $3.55 | 369,770 |
| Apr 6, 2026 | James Rodbergofficer: Chief Financial Officer | Sale | 7,231 | $3.55 | 230,939 |
House and Senate disclosures
Not reported.
